Saha, Tanmoy
Dash, Chinmayee http://orcid.org/0000-0002-2677-603X
Jayabalan, Ruparoshni
Khiste, Sachin
Kulkarni, Arpita http://orcid.org/0000-0003-0775-8044
Kurmi, Kiran
Mondal, Jayanta
Majumder, Pradip K.
Bardia, Aditya http://orcid.org/0000-0003-4885-1157
Jang, Hae Lin
Sengupta, Shiladitya http://orcid.org/0000-0002-8065-5052
Funding for this research was provided by:
U.S. Department of Defense (PC180355)
American Lung Association
Article History
Received: 17 June 2019
Accepted: 7 September 2021
First Online: 18 November 2021
Competing interests
: S.S. is a co-founder and owns equity in Vyome Therapeutics, Akamara Therapeutics and Invictus Oncology, and receives fees from Famygen and Advamedica. H.L.J. is a founder and owns equity in Curer. A.B. is involved in the following consulting/advisory boards: Pfizer, Novartis, Genentech, Merck, Radius Health, Immunomedics, Taiho, Sanofi, Daiichi Pharma/AstraZeneca, Puma, Biothernostics, Phillips, Eli Lilly and Foundation Medicine; A.B. is also contracted via research/grant to the following institutions: Genentech, Novartis, Pfizer, Merck, Sanofi, Radius Health, Immunomedics, Daiichi Pharma/AstraZeneca and Natera. T.S., C.D., R.J., S.K., A.K., K.K., J.M. and P.K.M. declare no competing interests.